{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:48:17Z","timestamp":1780361297152,"version":"3.54.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82003593"],"award-info":[{"award-number":["82003593"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2019CFB104"],"award-info":[{"award-number":["2019CFB104"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fitoterapia"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.fitote.2024.106091","type":"journal-article","created":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T16:02:48Z","timestamp":1718899368000},"page":"106091","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Design, synthesis, and biological studies of nitric oxide-donating piperlongumine derivatives triggered by lysyl oxidase as anti-triple negative breast cancer agents"],"prefix":"10.1016","volume":"177","author":[{"given":"Yu","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zedan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fitote.2024.106091_bb0005","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.1021\/acsbiomaterials.2c00277","article-title":"Three-dimensional in vitro models: a promising tool to scale-up breast cancer research","volume":"8","author":"Azimian Zavareh","year":"2022","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.fitote.2024.106091_bb0010","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.annonc.2019.10.012","article-title":"Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy: current evidence and future challenges","volume":"31","author":"Heil","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.fitote.2024.106091_bb0015","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.3892\/ijo.2020.5135","article-title":"Triple-negative breast cancer therapy: current and future perspectives (review)","volume":"57","author":"Won","year":"2020","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.fitote.2024.106091_bb0020","doi-asserted-by":"crossref","first-page":"104683","DOI":"10.1016\/j.phrs.2020.104683","article-title":"Tumor microenvironment: challenges and opportunities in targeting metastasis of triple negative breast cancer","volume":"153","author":"Deepak","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.fitote.2024.106091_bb0025","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2217\/pgs-2017-0117","article-title":"Triple-negative breast cancer and the potential for targeted therapy","volume":"18","author":"Jhan","year":"2017","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.fitote.2024.106091_bb0030","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1007\/s13346-018-0551-3","article-title":"Metastatic and triple-negative breast cancer: challenges and treatment options","volume":"8","author":"Al-Mahmood","year":"2018","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.fitote.2024.106091_bb0035","doi-asserted-by":"crossref","first-page":"4616","DOI":"10.1021\/acs.jmedchem.1c01646","article-title":"Gefitinib-tamoxifen hybrid ligands as potent agents against triple-negative breast cancer","volume":"65","author":"Abdelmalek","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.fitote.2024.106091_bb0040","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1021\/acsbiomaterials.1c01582","article-title":"Hitting multiple cellular targets in triple-negative breast cancer using dual-action cisplatin(iv) prodrugs for safer synergistic chemotherapy","volume":"8","author":"Date","year":"2022","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.fitote.2024.106091_bb0045","doi-asserted-by":"crossref","first-page":"12383","DOI":"10.1021\/acsnano.3c01792","article-title":"A paclitaxel prodrug with copper depletion for combined therapy toward triple-negative breast cancer","volume":"17","author":"Hao","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.fitote.2024.106091_bb0050","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1021\/acsomega.8b02323","article-title":"Photodynamic activity of vitamin-chlorin conjugates at nanomolar concentrations against triple-negative breast cancer cells","volume":"4","author":"Isaac-Lam","year":"2019","journal-title":"ACS Omega"},{"key":"10.1016\/j.fitote.2024.106091_bb0055","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1021\/acs.molpharmaceut.2c00701","article-title":"Camptothesome potentiates pd-l1 immune checkpoint blockade for improved metastatic triple-negative breast cancer immunochemotherapy","volume":"19","author":"Wang","year":"2022","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.fitote.2024.106091_bb0060","doi-asserted-by":"crossref","first-page":"29385","DOI":"10.1021\/acsami.8b11723","article-title":"Loading lovastatin into camptothecin\u2013floxuridine conjugate nanocapsules for enhancing anti-metastatic efficacy of cocktail chemotherapy on triple-negative breast cancer","volume":"10","author":"Zhang","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.fitote.2024.106091_bb0065","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1021\/jm030825u","article-title":"New potential uroselective no-donor \u03b11-antagonists","volume":"46","author":"Boschi","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.fitote.2024.106091_bb0070","doi-asserted-by":"crossref","first-page":"7617","DOI":"10.1021\/acs.jmedchem.6b01672","article-title":"Nitric oxide donor-based cancer therapy: advances and prospects","volume":"60","author":"Huang","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.fitote.2024.106091_bb0075","first-page":"189001","article-title":"Insights on the functional dualism of nitric oxide in the hallmarks of cancer","volume":"2023","author":"Panneerselvan","year":"1878","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.fitote.2024.106091_bb0080","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1021\/ol7019636","article-title":"Nitric oxide prodrugs: Diazeniumdiolate anions of hindered secondary amines","volume":"9","author":"Chakrapani","year":"2007","journal-title":"Org. Lett."},{"key":"10.1016\/j.fitote.2024.106091_bb0085","doi-asserted-by":"crossref","first-page":"28907","DOI":"10.1021\/acsami.3c02506","article-title":"Nitric oxide-releasing hemodialysis catheter lock solutions","volume":"15","author":"Maloney","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.fitote.2024.106091_bb0090","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1367-5931(02)00383-6","article-title":"The decomposition of thionitrites","volume":"6","author":"Stamler","year":"2002","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.fitote.2024.106091_bb0095","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2174\/1568026054679281","article-title":"An introduction to no-related therapeutic agents","volume":"5","author":"Thatcher","year":"2005","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.fitote.2024.106091_bb0100","first-page":"323","article-title":"The promising potential of piperlongumine as an emerging therapeutics for cancer","volume":"2","author":"Parama","year":"2021","journal-title":"Explor. Target. Antitumor. Ther."},{"key":"10.1016\/j.fitote.2024.106091_bb0105","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ejps.2012.12.003","article-title":"Overview of the therapeutic potential of piplartine (piperlongumine)","volume":"48","author":"Bezerra","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.fitote.2024.106091_bb0110","doi-asserted-by":"crossref","first-page":"113471","DOI":"10.1016\/j.ejmech.2021.113471","article-title":"Overview of piperlongumine analogues and their therapeutic potential","volume":"220","author":"Zhu","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.fitote.2024.106091_bb0115","doi-asserted-by":"crossref","first-page":"110243","DOI":"10.1016\/j.biopha.2020.110243","article-title":"Piperlongumine induces ros mediated cell death and synergizes paclitaxel in human intestinal cancer cells","volume":"128","author":"Rawat","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.fitote.2024.106091_bb0120","doi-asserted-by":"crossref","first-page":"104772","DOI":"10.1016\/j.phrs.2020.104772","article-title":"Piperlongumine, a potent anticancer phytotherapeutic: perspectives on contemporary status and future possibilities as an anticancer agent","volume":"156","author":"Tripathi","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.fitote.2024.106091_bb0125","doi-asserted-by":"crossref","first-page":"107658","DOI":"10.1016\/j.intimp.2021.107658","article-title":"A natural product, piperlongumine (pl), increases tumor cells sensitivity to nk cell killing","volume":"96","author":"Afolabi","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.fitote.2024.106091_bb0130","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3390\/molecules25010216","article-title":"Two natural alkaloids synergistically induce apoptosis in breast cancer cells by inhibiting stat3 activation","volume":"25","author":"Chen","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.fitote.2024.106091_bb0135","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.3390\/molecules24122338","article-title":"Piperlongumine induces apoptosis and synergizes with doxorubicin by inhibiting the jak2-stat3 pathway in triple-negative breast cancer","volume":"24","author":"Chen","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.fitote.2024.106091_bb0140","doi-asserted-by":"crossref","first-page":"109832","DOI":"10.1016\/j.cbi.2022.109832","article-title":"Piperlongumine induces ros mediated apoptosis by transcriptional regulation of smad4\/p21\/p53 genes and synergizes with doxorubicin in osteosarcoma cells","volume":"354","author":"Rawat","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.fitote.2024.106091_bb0145","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.cclet.2020.08.049","article-title":"Radiosensitization of human pancreatic cancer by piperlongumine analogues","volume":"32","author":"Ma","year":"2021","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.fitote.2024.106091_bb0150","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ejmech.2014.05.070","article-title":"Design, synthesis and biological activity of piperlongumine derivatives as selective anticancer agents","volume":"82","author":"Wu","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.fitote.2024.106091_bb0155","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.abb.2013.12.022","article-title":"Human copper-dependent amine oxidases","volume":"546","author":"Finney","year":"2014","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.fitote.2024.106091_bb0160","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrc3319","article-title":"The rationale for targeting the lox family in cancer","volume":"12","author":"Barker","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.fitote.2024.106091_bb0165","doi-asserted-by":"crossref","first-page":"103624","DOI":"10.1016\/j.jtherbio.2023.103624","article-title":"Denatured collagen inhibits neuroblastoma tumor-sphere migration and growth via the lox\/loxl2-fak signaling pathway","volume":"115","author":"Bui","year":"2023","journal-title":"J. Therm. Biol."},{"key":"10.1016\/j.fitote.2024.106091_bb0170","doi-asserted-by":"crossref","first-page":"6893","DOI":"10.1039\/C8SC00167G","article-title":"O2-3-Aminopropyl diazeniumdiolates suppress the progression of highly metastatic triple-negative breast cancer by inhibition of microvesicle formation via nitric oxide-based epigenetic regulation","volume":"34","author":"Kang","year":"2018","journal-title":"Chem. Sci."},{"key":"10.1016\/j.fitote.2024.106091_bb0175","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ejmech.2017.06.046","article-title":"Synthesis and evaluation of N-heteroaromatic ring-based analogs of piperlongumine as potent anticancer agents","volume":"138","author":"Zou","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.fitote.2024.106091_bb0180","doi-asserted-by":"crossref","first-page":"104670","DOI":"10.1016\/j.fitote.2020.104670","article-title":"Development of a novel truncated deguelin derivative possessing nitric oxide donor as a potential anti-lung cancer agent","volume":"146","author":"Zhou","year":"2020","journal-title":"Fitoterapia"}],"container-title":["Fitoterapia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0367326X24002740?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0367326X24002740?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T05:57:36Z","timestamp":1723096656000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0367326X24002740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":36,"alternative-id":["S0367326X24002740"],"URL":"https:\/\/doi.org\/10.1016\/j.fitote.2024.106091","relation":{},"ISSN":["0367-326X"],"issn-type":[{"value":"0367-326X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and biological studies of nitric oxide-donating piperlongumine derivatives triggered by lysyl oxidase as anti-triple negative breast cancer agents","name":"articletitle","label":"Article Title"},{"value":"Fitoterapia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fitote.2024.106091","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106091"}}